Molecular Partners AG (MOLN)
NASDAQ: MOLN · Real-Time Price · USD
5.42
+0.22 (4.23%)
Nov 21, 2024, 3:40 PM EST - Market closed
Molecular Partners AG Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 200 | 134 | 217 | 631 | 684 | 390 | |
Market Cap Growth | 24.06% | -38.09% | -65.65% | -7.66% | 75.45% | -5.25% | |
Enterprise Value | 41 | -106 | -67 | 469 | 613 | 266 | |
Last Close Price | 5.20 | 4.18 | 6.55 | 19.18 | - | - | |
PE Ratio | - | - | 1.70 | - | - | - | |
PS Ratio | 24.17 | 16.06 | 1.06 | 58.99 | 64.72 | 18.51 | |
PB Ratio | 1.05 | 0.64 | 0.85 | 5.36 | 5.64 | 6.97 | |
P/TBV Ratio | 1.05 | 0.64 | 0.85 | 5.38 | 5.66 | 7.07 | |
P/FCF Ratio | - | - | 1.71 | - | - | - | |
P/OCF Ratio | - | - | 1.69 | - | - | - | |
EV/Sales Ratio | 5.82 | - | - | 43.83 | 58.04 | 12.62 | |
Debt / Equity Ratio | 0.02 | 0.02 | 0.02 | 0.06 | 0.07 | 0.05 | |
Debt / EBITDA Ratio | - | - | 0.04 | - | - | - | |
Debt / FCF Ratio | - | - | 0.04 | - | - | - | |
Asset Turnover | 0.03 | 0.03 | 0.87 | 0.05 | 0.06 | 0.16 | |
Quick Ratio | 14.08 | 13.09 | 14.53 | 3.38 | 3.06 | 3.40 | |
Current Ratio | 14.33 | 13.35 | 14.77 | 3.50 | 3.08 | 3.49 | |
Return on Equity (ROE) | -37.37% | -30.12% | 68.83% | -59.47% | -77.79% | -49.76% | |
Return on Assets (ROA) | -21.17% | -16.58% | 33.52% | -22.01% | -24.93% | -17.62% | |
Return on Capital (ROIC) | -23.07% | -18.18% | 41.25% | -34.80% | -42.61% | -30.88% | |
Earnings Yield | -36.99% | -54.84% | 58.79% | -11.08% | -10.38% | -9.62% | |
FCF Yield | -35.43% | -52.72% | 58.56% | -15.97% | -5.03% | -0.59% | |
Buyback Yield / Dilution | -1.02% | 1.49% | -7.29% | -24.02% | -16.75% | -1.16% | |
Total Shareholder Return | -1.02% | 1.49% | -7.29% | -24.02% | -16.75% | -1.16% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.